PTC Therapeutics | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amgen USD 747M 29M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Cytokinetics USD 22.59M 296K 2024-12
Daiichi Sankyo 11.62B 11.42B 2024-09
Gilead Sciences USD 248M 10M 2024-12
Incyte USD 419K 355K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Ironwood Pharmaceuticals USD 9.25M 2.15M 2024-09
Novartis USD 275M 11M 2024-12
Pfizer USD 739M 45M 2024-12
PTC Therapeutics USD 42.11M 1.09M 2024-09
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
TG Therapeutics USD 10.83M 6.86M 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Xencor -39359000 40.15M 2024-12



PTC Therapeutics Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.